Clinical significance of immunohistochemically detectable epithelial cells in sentinel lymph node and bone marrow in breast cancer
- 21 April 2003
- journal article
- editorial
- Published by Wiley in Journal of Surgical Oncology
- Vol. 83 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Revision of the American Joint Committee on Cancer Staging System for Breast CancerJournal of Clinical Oncology, 2002
- Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, PennsylvaniaCancer, 2002
- Image-Detected Breast Cancer: State of The Art Diagnosis and TreatmentJournal of the American College of Surgeons, 2001
- Epithelial Cells in Bone Marrow of Breast Cancer Patients at Time of Primary Surgery: Clinical Outcome During Long-Term Follow-UpJournal of Clinical Oncology, 2001
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Benign Transport of Breast Epithelium Into Axillary Lymph Nodes After BiopsyAmerican Journal of Clinical Pathology, 2000
- Role of immunohistochemical detection of lymph-node metastases in management of breast cancerThe Lancet, 1999
- Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up studyThe Lancet, 1999
- Late mortality from pT1N0M0 breast carcinomaCancer, 1999
- The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the BreastNew England Journal of Medicine, 1999